Fundraising FoxSevion Therapeutics
San Diego, US · Delaware corporation
Find your way into Sevion Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
113 people can intro you to Miguel
Ask Monal Mehta to introduce you to Miguel de los Rios
You →Monal · together at Endeavor Biomedicines →Miguel
Sign up to find every way you can get introduced to Sevion Therapeutics
- Your email: who you already know at Sevion Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sevion Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
MA
Miguel A. de los RiosVice President of Research & Development2014–2018Miguel de los Rios founded Chimeros, Inc., a biologics company, in 2003 while completing his PhD in Biophysical Chemistry from UC Santa Barbara. He has held R&D and leadership roles at multiple therapeutic companies including Rift Biotherapeutics and Sevion Therapeutics, with published research across biologics and oncology.
VS
Vaughn SmiderExecutive
DR
David RectorExecutive
JG
James GrazianoExecutive
Board
PF
Phillip FrostBoard director
SR
Steven RubinBoard director
JB
John BracaBoard director
HW
Harlan W. WaksalBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2015
▶$3MraisedMay 2015 · 14 investors · BiotechnologyRule 506(b)
▶$3MraisedMay 2015 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel A. de los RiosExecutive Officer
- Vaughn SmiderExecutive Officer, Director
- John BracaDirector
- Phillip FrostDirector
- Joel BrooksExecutive Officer
- David RectorExecutive Officer, Director
- Steven RubinDirector
- Harlan W. WaksalDirector
- James GrazianoExecutive Officer
- Offering amount
- $10M
- Amount sold
- $3M
- Minimum investment
- $25K
- Sales commissions
- $190.5K
- Placement agents
- Axiom Capital Management, Inc., Laidlaw & Company (UK), Ltd., Newport Coast Securities, Inc., Palladium Capital Advisors, LLC
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Sevion Therapeutics raised?
- Sevion Therapeutics has disclosed $3M raised across 1 round.
- Where is Sevion Therapeutics headquartered?
- Sevion Therapeutics is headquartered in San Diego, US.